# Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1

> **NCT03007719** · PHASE2 · TERMINATED · sponsor: **Lawrence Fong** · enrollment: 4 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Fluorine F 18 Ara-G
- **PROCEDURE:** Positron Emission Tomography
- **PROCEDURE:** Magnetic Resonance Imaging

## Key facts

- **NCT ID:** NCT03007719
- **Lead sponsor:** Lawrence Fong
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-03-07
- **Primary completion:** 2019-01-11
- **Final completion:** 2019-01-11
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Low Accrual
- **Last updated:** 2020-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03007719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03007719, "Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03007719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*